
### [NCIT:C5716](http://purl.obolibrary.org/obo/NCIT_C5716)
**Label:** Borderline Exocrine Pancreatic Neoplasm

**Subclasses:** [NCIT:C4845](http://purl.obolibrary.org/obo/NCIT_C4845) (Pancreatic Intraepithelial Neoplasia), [NCIT:C4846](http://purl.obolibrary.org/obo/NCIT_C4846) (Pancreatic Intraepithelial Neoplasia-2), [NCIT:C6820](http://purl.obolibrary.org/obo/NCIT_C6820) (Pancreatic Intraepithelial Neoplasia-1), [NCIT:C95488](http://purl.obolibrary.org/obo/NCIT_C95488) (Non-Invasive Pancreatic Mucinous-Cystic Neoplasm), [NCIT:C95432](http://purl.obolibrary.org/obo/NCIT_C95432) (Pancreatic Intraepithelial Neoplasia-3), [NCIT:C95430](http://purl.obolibrary.org/obo/NCIT_C95430) (Pancreatic Intraepithelial Neoplasia-1B), [NCIT:C95483](http://purl.obolibrary.org/obo/NCIT_C95483) (Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia), [NCIT:C41249](http://purl.obolibrary.org/obo/NCIT_C41249) (Pancreatic Intraductal Papillary-Mucinous Neoplasm with Low Grade Dysplasia), [NCIT:C95493](http://purl.obolibrary.org/obo/NCIT_C95493) (Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia), [NCIT:C95506](http://purl.obolibrary.org/obo/NCIT_C95506) (Pancreatic Intraductal Tubulopapillary Neoplasm), [NCIT:C95429](http://purl.obolibrary.org/obo/NCIT_C95429) (Pancreatic Intraepithelial Neoplasia-1A), [NCIT:C41251](http://purl.obolibrary.org/obo/NCIT_C41251) (Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia), [NCIT:C5719](http://purl.obolibrary.org/obo/NCIT_C5719) (Pancreatic Intraductal Papillary-Mucinous Neoplasm with Intermediate Grade Dysplasia), 

**Class expressions from DL-Learner:**

- [UBERON:0000017](http://purl.obolibrary.org/obo/UBERON_0000017) (exocrine pancreas) 60.00%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 60.00%
- [UBERON:0000409](http://purl.obolibrary.org/obo/UBERON_0000409) (serous gland) and [UBERON:0005177](http://purl.obolibrary.org/obo/UBERON_0005177) (trunk region element) 60.00%
- [UBERON:0000409](http://purl.obolibrary.org/obo/UBERON_0000409) (serous gland) and [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) 60.00%
- Thing 51.79%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 45.36%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C121967](http://purl.obolibrary.org/obo/NCIT_C121967) (Meningioangiomatosis))) 45.36%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C121966](http://purl.obolibrary.org/obo/NCIT_C121966) (Loss of INI 1 Protein Expression))) 45.36%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C121963](http://purl.obolibrary.org/obo/NCIT_C121963) (Cribriform Neuroepithelial Tumor))) 45.36%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C121953](http://purl.obolibrary.org/obo/NCIT_C121953) (Ovarian Microcystic Stromal Tumor))) 45.36%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C121941](http://purl.obolibrary.org/obo/NCIT_C121941) (Bone Epithelioid Hemangioendothelioma))) 45.36%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C121932](http://purl.obolibrary.org/obo/NCIT_C121932) (Giant Cell Tumor of Bone))) 45.36%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C121930](http://purl.obolibrary.org/obo/NCIT_C121930) (Primary Non-Hodgkin Lymphoma of Bone))) 45.36%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C121929](http://purl.obolibrary.org/obo/NCIT_C121929) (Non-Ossifying Fibroma))) 45.36%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C121924](http://purl.obolibrary.org/obo/NCIT_C121924) (Enostosis))) 45.36%


